Impaired Fasting Glucose
Conditions
Interventions
Healthy individual group: In the glycemic index (GI) determination trial, healthy subjects will undergo multiple test sessions, each involving the consumption of 50 g of carbohydrates in the form of e
The group with impaired fasting glucose:In the dietary intervention trial: "Conventional soft rice" diet:? The staple food was prepared using commercially available Nanjing 9108 rice, cooked with a ri
Sponsors
Northern Jiangsu People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Healthy Volunteers: (1) Healthy adults aged 18 to 65 years old, excluding pregnant women and lactating mothers; (2) Body Mass Index (BMI) within the normal range: 18.5 to 23.9 kg/m^2; (3) No history of diabetes or other metabolic diseases, normal fasting blood glucose and results of OGTT test; (4) No medication taken within the past 1 week; (5) Voluntarily signed the informed consent form after fully understanding the trial. 2. IFG Population: (1) Age 18 to 65 years old; (2) Abnormal fasting blood glucose indicators: Two fasting blood glucose measurements >= 6.1 mmol/L but < 7 mmol/L; 2-hour post-meal blood glucose < 7.8 mmol/L; (3); (4) In fully understanding the trial, voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Healthy volunteers: (1) Have gastrointestinal diseases: ulcerative colitis, active peptic ulcers, etc.; (2) Have allergic constitution: allergic to rice or multiple foods; (3) Have poor compliance; (4) Reasons as determined by the researchers that they are not suitable to participate in this study. 2. IFG population: (1) Have gastrointestinal diseases: ulcerative colitis, active peptic ulcers, etc.; (2) Pregnant or lactating; (3) Have allergic constitution: allergic to rice or multiple foods; (4) Have difficulty in moving, or have impaired consciousness; (5) Have acute infections, surgeries, or traumas within the last month; (6) Participate in another clinical research trial; (7) Have poor compliance; (8) Reasons as determined by the researchers that they are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incremental Area Under the Curve of Postprandial Blood Glucose;Postprandial blood glucose increment;Time to peak postprandial glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting venous blood glucose;Triglycerides;Total Cholesterol;Low Density Lipoprotein Cholesterol;High Density Lipoprotein Cholesterol; | — |
Countries
China
Contacts
Public ContactJian Shao
Northern Jiangsu People's Hospital
Outcome results
None listed